Semaglutide
STEP 1
Novo Nordisk · Phase 3 · Completed · Enrollment 1961
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Semaglutide s.c. 2.4 mg once weekly | n/r | n/r | n/r | n/r | n/r |
| Semaglutide placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.